Peer Exchange

Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.

Studies of Biologics on Cardiovascular Outcomes and Cost
December 03, 2019 – 
The panel discuss the studies looking at treating patients with biologics even in patients with comorbidities.
Understanding Plan B vs Plan D Coverage
December 03, 2019 – 
A review of the Plan B and Plan D insurance coverage and the products that are covered differently based on administration.
Insomnia Management: Creating a Treatment Paradigm
November 27, 2019 – 
Key opinion leaders discuss the need to create a treatment paradigm for patients with insomnia.
The Impact of DORA Treatment
November 27, 2019 – 
Peter L. Salgo, MD, leads a discussion on the suvorexant study involving patients with Alzheimer disease, and its implications for the treatment of patients with insomnia.
Dosing Impact on Patient Adherence and Patient Preference
November 26, 2019 – 
Panelists discuss the impact of dosing schedules on patient adherence and preference.
Improving Patient Adherence
November 26, 2019 – 
A discussion on patient adherence and how to help improve compliance.
The High-Risk Patient Populations
November 21, 2019 – 
A consideration of the high-risk patient strata and the limitations on medications used in older individuals with preexisting conditions.
Treatment Selection: The Beers Criteria
November 21, 2019 – 
Key opinion leaders discuss the 2019 updates from the American Geriatrics Society on the Beers Criteria, and their significance in determining appropriate medications.
IL-23: Long-term Data and Safety Data
November 19, 2019 – 
A review of the IL-23 inhibitors and their long-term and safety data.
Decreased Efficacy, PASI Score vs BSA, and Nonresponders
November 19, 2019 – 
The panel discusses the potential for decreased efficacy of treatment based on comorbidities. They also discuss the use of PASI score vs BSA to determine severity of disease and the need to identify responders and nonresponders to specific agents.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.